Zucara Therapeutics Announces US$21M Series A Financing
– Proceeds to Fund Development of ZT-01 Through Phase 2 Clinical Trials – – Series A Financing led by the Perceptive Xontogeny Venture Fund – TORONTO, March 31, 2020 (GLOBE…
Quick Links
Contact Us
MaRS Centre, West Tower
661 University Avenue, Suite 465
Toronto, ON M5G 1M1
info@tiap.ca